Skip to main content
Caplight Logo









SeaBeLife

SeaBeLife

Private
RoscoffHealthcare & Life Scienceshttps://www.seabelife.com/en/

Last Round

Early Funding

Oct 1, 2025

Total Funding Raised

$5.59M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

SeaBeLife is a biotechnology company that develops small-molecule therapies designed to protect tissues by simultaneously inhibiting necroptosis and ferroptosis, two regulated cell-death pathways.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoverysmall-molecule therapeuticsnecroptosisferroptosiscell death inhibitionbiotech startupage-related macular degenerationAMDacute liver failuredual-inhibitor technologydrug licensingpreclinical developmentregenerative medicinepharma pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SeaBeLife Comparables

Compare SeaBeLife with similar companies based on industry and business-model similarity.

SeaBeLife comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Miramón Pharma S.L.
85%
FELIQS Corporation
81%
LinkGevity Limited
80%

SeaBeLife Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingOct 1, 2025
GrantApr 22, 2024
SeedSep 26, 2023

SeaBeLife Investors

Notable investors and investment history

SeaBeLife investors
InvestorRounds
Les Business Angels des Grandes ÉcolesSeed, Early Funding
WeLikeStartupEarly Funding
Angels SantéSeed, Early Funding
Femmes Business AngelsEarly Funding
ADEME - Agence de la transition écologiqueGrant
iXLife CapitalSeed, Early Funding
BpifranceGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 166% MoM, reaching 2.1K.

  • Jun 19, 2026

    Monthly visitors increased 60% MoM.

SeaBeLife Filings

Explore SEC and related filing metadata, where available.

SeaBeLife filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about SeaBeLife's valuation, stock price, and market status.

Is SeaBeLife a public or private company?

SeaBeLife is a private company.

What is the current stock price of SeaBeLife?

SeaBeLife is a private company with no public stock price. Caplight tracks SeaBeLife's secondary market activity and provides MarketPrice estimates to Caplight users.

How much is SeaBeLife worth (valuation)?

Valuation information for SeaBeLife is not publicly available.

Can I buy SeaBeLife stock?

SeaBeLife shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was SeaBeLife's last funding round?

SeaBeLife's most recent funding round was Early Funding on October 1, 2025.

Who are the main investors in SeaBeLife?

Key investors in SeaBeLife include iXLife Capital.

Will SeaBeLife IPO soon?

No public IPO plans have been announced for SeaBeLife.

How can I track SeaBeLife secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SeaBeLife's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersRoscoff
Employee Range8
Year Founded2019
Last FundingOct 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?